Adaptive oncology Phase I trial design of drug combinations with drug-drug interaction modeling (Q1782097)
From MaRDI portal
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Adaptive oncology Phase I trial design of drug combinations with drug-drug interaction modeling |
scientific article |
Statements
Adaptive oncology Phase I trial design of drug combinations with drug-drug interaction modeling (English)
0 references
18 September 2018
0 references
adaptive Bayesian design
0 references
Bliss independence
0 references
drug combination
0 references
dose finding
0 references
interaction index function
0 references
maximum tolerated dose (MTD)
0 references
maximum tolerated region
0 references
objective function
0 references
